Immusoft Obtains $375,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    454 N 34th St. Seattle, WA 98103 USA
  • Company Description
    Our Immune System Programming (ISP) technology turns a patient’s own B cells into miniature drug factories. Immusoft’s mission is to develop a completely new platform for delivering medicines – programming a patient’s own cells to become miniature drug factories.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy